A comprehensive view of new use. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Abbott announces approval in Japan to expand reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day; device is a continuous glucose monitoring system
Published: March 24, 2022 by Abbott Laboratories
Novavax announces emergency use authorization for Novavax protein-based COVID-19 vaccine for adolescents aged 12 to 18 in India; vaccine is manufactured and marketed in India by Serum Institute of India under the brand Covovax
Published: March 23, 2022 by Novavax Inc.
Merck announces FDA approval of Keytruda intravenous infusion as a single agent for treatment of advanced endometrial carcinoma
Published: March 21, 2022 by Merck & Co. Inc.
Moderna submits request to the FDA for amendment to the emergency use authorization of its mRNA COVID-19 vaccine in adults, to allow for a fourth dose; broad approval will allow CDC, health care providers to determine who should receive a booster dose
Published: March 18, 2022 by Moderna Inc.
Pfizer and BioNTech submit application to FDA for Emergency Use Authorization of an additional COVID-19 vaccine booster for adults aged 65 and older; application is based on real-world data from Israel when Omicron variant was circulating
Published: March 16, 2022 by Pfizer Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count